Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus 0.1% versus glucocorticoid for moderate-to-severe dry eye
ChiCTR-IPQ-15006773Phase 4Recruiting
- Sponsor
- Eye Institute of Xiamen University
- Start
- Jul 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in dry eye syndrome (DED) (3 arms), sponsored by Eye Institute of Xiamen University. Primary endpoints: Dry eye questionnaire, Conjunctival papillae and 2 more. Started Jul 2015; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR-IPQ-15006773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPQ-15006773.